SCHEMBL175269

SCHEMBL175269

CCS(=O)(=O)c1ccc(CC(=O)Nc2nc(-c3cccc(Cl)c3)c(C(=O)c3ccccc3Cl)s2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RORC P51449 20/20 1.00
RORB Q92753 3/20 1.00
NR1I2 O75469 1/20 1.00
RORA P35398 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175635 0.93 RORC (0.86) RORCRORBNR1I2RORA
SCHEMBL175550 0.92 RORC (0.86) RORCRORBNR1I2RORA
SCHEMBL175214 0.92 RORC (0.85) RORCRORBNR1I2RORA
SCHEMBL175442 0.92 RORC (1.00) RORCRORBNR1I2RORA
SCHEMBL175284 0.91 RORC (0.84) RORCRORBNR1I2RORA
SCHEMBL175604 0.91 RORC (0.83) RORCRORBNR1I2RORA
SCHEMBL174641 0.90 RORC (1.00) RORCRORBNR1I2
SCHEMBL175313 0.90 RORC (0.81) RORCRORBNR1I2RORA
SCHEMBL175182 0.90 RORC (0.81) RORCRORBNR1I2RORA
SCHEMBL175507 0.89 RORC (1.00) RORCRORBNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090499-A1 COMPOSITIONS AND METHODS FOR IMPROVING BONE HEALTH USING SELF-EMULSIFYING FORMULATIONS OF DIINDOLYLMETHANE BIORESPONSE, L.L.C. 2025-03-20 US disclosed
US-20220280479-A1 SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES BIORESPONSE, L.L.C. 2022-09-08 US disclosed
US-11337961-B2 Self-emulsifying formulations of DIM-related indoles BIORESPONSE, L.L.C. (US) 2022-05-24 US disclosed
CN-108473426-B Cyclic amine derivative and medical use thereof 东丽株式会社 2021-09-07 CN disclosed
US-20210046046-A1 SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES BIORESPONSE, L.L.C. 2021-02-18 US disclosed
US-10881649-B2 Therapeutic agent or preventive agent for alopecia areata TORAY INDUSTRIES, INC. (JP) 2021-01-05 US disclosed
US-10799479-B2 Self-emulsifying formulations of DIM-related indoles BIORESPONSE, L.L.C. (US) 2020-10-13 US disclosed
US-20200215046-A1 THERAPEUTIC AGENT OR PREVENTIVE AGENT FOR ALOPECIA AREATA TORAY INDUSTRIES, INC. (JP) 2020-07-09 US disclosed
EP-3409660-B1 CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF TORAY INDUSTRIES (JP) 2020-07-01 EP disclosed
EP-3659602-A1 THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR ALOPECIA AREATA Toray Industries, Inc. (JP) 2020-06-03 EP disclosed
US-10441569-B2 Self-emulsifying formulations of DIM-related indoles BIORESPONSE, L.L.C. (US) 2019-10-15 US disclosed
US-10364222-B2 Cyclic amine derivative and medical use thereof TORAY INDUSTRIES, INC. (JP) 2019-07-30 US disclosed
US-20180370916-A1 CYCLIC AMINE DERIVATIVE AND MEDICAL USE THEREOF TORAY INDUSTRIES, INC. (JP) 2018-12-27 US disclosed
EP-3409660-A1 CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF Toray Industries, Inc. (JP) 2018-12-05 EP disclosed
US-20180280347-A1 SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES BIORESPONSE, L.L.C. (US) 2018-10-04 US disclosed
US-20180161308-A1 SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES BIORESPONSE, L.L.C. (US) 2018-06-14 US disclosed
EP-3280398-A1 SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES Bioresponse LLC (US) 2018-02-14 EP disclosed
WO-2016164770-A1 SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES BIORESPONSE, L.L.C. (US) 2016-10-13 WO disclosed
WO-2012027965-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2012-03-08 WO disclosed
WO-2012027965-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220280479-A1 SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES IDO1, IDO2, CYP8B1 RORC 933/4885RORB 228/4885NR1I2 2345/4885
US-20250090499-A1 COMPOSITIONS AND METHODS FOR IMPROVING BONE HEALTH USING SELF-EMULSIFYING FORMULATIONS OF DIINDOLYLMETHANE IDO1, AHR, IDO2 RORC 1526/4885RORB 522/4885NR1I2 3038/4885
US-20200215046-A1 THERAPEUTIC AGENT OR PREVENTIVE AGENT FOR ALOPECIA AREATA RORA, RORB, RORC RORC 3/4885RORB 2/4885NR1I2 64/4885
US-10441569-B2 Self-emulsifying formulations of DIM-related indoles IDO1, IDO2, CYP8B1 RORC 933/4885RORB 228/4885NR1I2 2345/4885
US-20180370916-A1 CYCLIC AMINE DERIVATIVE AND MEDICAL USE THEREOF RORC, RORB, HRH3 RORC 1/4885RORB 2/4885NR1I2 113/4885
US-20210046046-A1 SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES IDO1, IDO2, CYP8B1 RORC 1131/4885RORB 221/4885NR1I2 1938/4885
US-11337961-B2 Self-emulsifying formulations of DIM-related indoles IDO1, IDO2, CYP8B1 RORC 1131/4885RORB 221/4885NR1I2 1938/4885
US-10364222-B2 Cyclic amine derivative and medical use thereof RORC, RORB, HRH3 RORC 1/4885RORB 2/4885NR1I2 113/4885
US-10881649-B2 Therapeutic agent or preventive agent for alopecia areata RORA, RORB, RORC RORC 3/4885RORB 2/4885NR1I2 64/4885
US-10799479-B2 Self-emulsifying formulations of DIM-related indoles IDO1, IDO2, CYP8B1 RORC 1131/4885RORB 221/4885NR1I2 1938/4885
US-20180280347-A1 SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES IDO1, IDO2, CYP8B1 RORC 1131/4885RORB 221/4885NR1I2 1938/4885
US-20180161308-A1 SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES IDO1, IDO2, CYP8B1 RORC 933/4885RORB 228/4885NR1I2 2345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.